Novo Nordisk open to direct New York listing, CEO Doustdar tells FT

Novo Nordisk OMXCOP:NOVO_B is open to considering a direct New York Stock Exchange listing, replacing the American depositary receipts through which US investors currently trade its shares, CEO Mike Doustdar told the Financial Times in an interview published on Wednesday.The US accounts for more th…